Good morning and welcome to Apollo Global Management's Fourth Quarter 2020 Earnings Conference Call. During today's discussion, all callers will be placed in a listen-only mode and following management's prepared remarks, the conference call will be open for question. This conference call is being recorded. This call may include forward-looking statement and projections which do not guarantee future events or performance. Please refer to Apollo's most recent SEC filings for risk factors related to these statements. Apollo will be discussing certain non-GAAP measures on this call which management believes are relevant in assessing the financial performance of the business. These non-GAAP measures are reconciled to GAAP figures in Apollo's earnings presentation which is available on the company's website. Also note that nothing on this call constitute an offer to sell or solicitation of an offer to purchase an interest in Apollo Fund. I would now like to turn the call over to Peter Mintzberg Head of Investor Relations.

Thanks operator and welcome to our fourth quarter 2020 earnings call. As many of you know, I joined the firm in November as Head of Investor Relations. And I'm very glad to be here with you all today for my first earnings call with Apollo. Joining me this morning are Marc Rowan, Josh Harris, and Martin Kelly. Jim Zelter and Scott Kleinman are also on the line for questions. I would like to turn it over to Marc to kick off our comments for today.

Thanks Peter. Good morning everyone. I'm excited to be here following the conclusion of my very poorly planned recent sabbatical. I look forward to engaging with our investors and shareholders as I transition into my new role. As you will hear in more detail the Apollo platform is strong, resilient, extremely well-positioned for growth in today's landscape as our exceptional 2020 results have demonstrated. Before I turn to the quarter and the year, I want to review the announcements that were contained in the various communications last week. I will first touch on governance, then leadership, and lastly our investors. In terms of governance, we believe the changes described in Leon's letter last week were an important step in our evolution from a private partnership to the standard set by the best public companies. Our industry is in transition. Our firm is in transition. All of us are moving from the small private partnerships that we started life as to important components of a more global financial system. Proper governance and transparency are going to be essential to play the role that we are supposed to play in this marketplace. Specifically as a firm, we are committed to moving promptly to a governance structure that will enhance our Board with additional diversity, possessing different viewpoints to bring experience to bear that is needed to help drive our business forward. We are committed to moving our Board to two-thirds independent over the near-term and we are committed to appointing a lead independent Director who will actively and regularly engage with the management and the Board. As it relates to Directors, we have already made substantial progress. Last week we announced that Pam Joyner and Sid Mukherjee will be joining our Board effective March 1st. Further, we are in active dialogue to…

Thanks Marc. We're all really glad to have you back from semi-sabbatical and in your up and coming role as CEO. I'd like to begin by acknowledging the unprecedented challenges we have all faced this past year with individuals as an organization and at society. The impact of this global health and economic crisis including illness, numerable losses, record unemployment and extreme market volatility are far-reaching and what we felt for a long, long time. Thank you to all the essential workers who have worked tirelessly to get us through this difficult time and who continue to push our country forward. Despite this challenging backdrop, Apollo delivered very strong results for the year, validating the resilience and differentiation of our business model. We acted quickly to help our investors, many of whom are the frontline workers getting us through this crisis, while at the same time helping many great companies during extenuating circumstances by providing liquidity solutions. We reported record inflows of $123 billion and achieved deployment activity of $88 billion. We generated record fee-related earnings of $2.37 per share reflecting 15% growth year-over-year and have surpassed $1 billion of FRE for the first time in our firm's history. In addition, we've exceeded $450 billion of AUM another milestone for the firm. For the fourth quarter we reported distributable earnings of $0.72 per common share; pretax fee-related earnings or FRE of $0.63 per share; and a cash dividend of $0.60 per share. We ended 2020 at $455 billion of AUM growing 38% year-over-year as a result of a record inflow year which included $13 billion of inflows for the fourth quarter. Organic growth accounted for 16% of the 38% increase in AUM and with two insurance transactions creating the remaining 22% increase. Specifically the $123 billion of inflows for the…

Thanks, Josh. Let me touch on FRE DE and dividend to start with. For the fourth quarter, management fees grew 3% over the prior quarter and 13% over the fourth quarter of 2019, driven by growth in fees for investing the assets of our insurance clients as well as deployment-driven growth in our credit and real assets businesses. For the full year 2020, management fees grew 11% over the prior year. Transaction and advisory fees were $81 million in the quarter, driven by capital solutions transactions and private equity activity. Compensation grew 8% over the prior quarter. This reflects our continued investment in growth initiatives across the firm, including support for our insurance businesses. Head count grew by more than 20% in each of the last two years, driven by the growth areas that Josh has highlighted. Non-compensation costs grew 12% over the prior quarter and included costs related to the independent review. For the fourth quarter, we announced a dividend of $0.60 per share and after-tax distributable earnings of $0.72 per share, our highest quarter since the fourth quarter of 2019. Our strong FRE of $0.63 per share were supported by net incentive earnings of $0.15 per share. Turning to incentive realizations. We realized $187 million of gross performance fees for the fourth quarter, primarily related to our credit strategies fund, which returned 24% in 2020. Gains from sales in Fund VIII will return to LPs as a result of the impairments recognized in the first half of 2020. At the end of the fourth quarter, the netting hole on Fund VIII had been reduced to $266 million equivalent to $0.06 per share of delayed net carry, down from $1.1 billion as of the second quarter. This fourth quarter reduction was driven principally by a secondary transaction for Voya…

Thank you, Martin. That concludes our remarks for today. Operator, please open the line for questions.

Thank you. [Operator Instructions] Our first question comes from Glenn Schorr with Evercore. Your line is open.

Hi. Thanks very much. Maybe one for Marc, just up at the top big picture, I think it's good to see, that back to the growth and growth on the front foot. But with credit insurance let's call it, 75% of assets, private equity already huge and great. I'm just curious as you think about building for the next decade, where real estate, infrastructure, retail capital markets like the other areas to grow and broaden Apollo to help our investors with your mission. I'd be curious to get your thoughts on that.

Okay. You touched on some of it, but I'll start with, how I think. The limit on our growth, which you're referring to, is not the ability to raise money. It's the ability to deploy it sensibly, in an Apollo-esque manner. In the private equity business, we are large. We will continue to grow, but you're right, that will not be a source of massive growth. The credit business is large, in a sense that we talk about. But in the context of the markets that we participate in, we're just beginning. We have an amazing opportunity in credit, particularly with respect to origination. In the real estate market which you also touched on, we have an immense real estate footprint. We simply don't group it in our financials or in our assets, because much of what we do in the real estate business is in yield, rather than an opportunity. We are building the real estate business. The real estate business is raising funds in the US opportunity market, in the Asian opportunity market, in the net lease market, in the debt market and in the core plus market. On every one of our insurance company balance sheets real estate is an expanding category. And I would expect our real estate business to increase. We have a lot of white space, but it has to be done in an Apollo-esque way. Infrastructure, Infrastructure 1, double-digit rates of return in the infrastructure market, back out in the market with infrastructure 2, again, an area that I expect to expand in a big way impact, exactly the same thing. Every one of these funds, the thing that ties them together, is not the desire to simply go out and raise AUM, but the identification of an opportunity that we believe, reflects Apollo. The Apollo investment brand fundamentally, means that we believe we are taking less risk, per unit of return, at every point in the capital structure from investment-grade down to the most opportunistic. To -- maybe I'll drone on for one more second. I think one of the biggest opportunities we have is to massively expand our front-end, which is our capacity to generate returns. This is bringing on board teams. This is buying in platforms. This is also building organically, from initiatives already underway within Apollo. I'll stop there.

Thank you. Our next question comes from Craig Siegenthaler with Credit Suisse. Your line is open.

Thanks. Good morning everyone. And I hope, you all are doing well and staying healthy. My question is, what is the potential time line for the full C-corp conversion?

So, we'll break Craig into, -- I'll give you an initial response, and then, I'll turn it over to Martin. So as I mentioned, we have asked our independent committee to promptly study and give us recommendations with respect to moving to one share one vote, and the other changes necessary to be eligible for broad index inclusion which would include a full C-corp conversion. I would expect we will hear back from them, no later than our next conference call. With that -- as to the specific steps, I'll turn it over to Martin.

Yeah, Craig, there's different ways that you can achieve, inclusion in indices. And so we're very familiar with what they are. And so, we're just -- they have different impacts and different time lines associated with them frankly. So we're working through all the details around that. And the approvals that will be needed from different constituents in view of what different outcomes might be. So we're -- we know what's ahead of us. We're working through all the considerations. And then we'll update you in due course.

Thank you. Our next question comes from Alex Blostein --. Your line is-- from Goldman Sachs. Your line is open.

Great, thank you. Good morning everybody. Marc I was hoping to dig in a little bit more into the LP feedback, since the completion of the investigation. You mentioned that you expect fundraising dynamics to build significantly from here, so maybe spend a minute on sort of the path and the time line for this acceleration. Which strategies do you expect to be most active contributors to the fundraising outlook for Apollo over the next 12 months? And then when you take a step back, are there common characteristics between LPs that are sort of satisfied with the process and the results of the investigation versus those that sort of need more time as you said in your earlier remarks? Thanks.

Okay. So I'll hit it up front. As to the specific strategies, I'll turn to Scott and Jim to talk about the strategies that are active in the market and where we think we're going to make the most progress in 2021. We've done a lot of limited partner and consultant calls. That's just – not just me. That's the entirety of our team. The vast majority of feedback from the LPs and consultants to date has been positive. They appreciate the seriousness and transparency and thought that we have put into this process. ESG are not just three initials to them or to us. This is something that we have to live every day. They have acknowledged that the report by Dechert substantiated what we told them, no involvement by Apollo or its employees and no wrongdoing on Leon's part. And they've commended us on the actions we've taken with respect to the governance changes and the succession planning. For the vast majority of LPs that will be enough. They think we've struck the right balance. For some LPs as I've said, they will want to see how these changes develop. And for some they will want to see these changes fully implemented. I do not believe that there is a specific characteristic across limited partners who perhaps are fully satisfied versus those who are less than fully satisfied at this point in time. But I will note with $455 billion of AUM and 1,500 institutional investors, something is happening in our funding business almost every day. In the fourth quarter, a number of people hit pause simply to wait to see the outcome. I believe in the first quarter we will see some of that pause simply come through and then we will get stronger every day. As to the specific products, why don't I start with Scott and then Scott will hand it to Jim.

Sure. So look on the opportunistic side, as Marc touched on a little bit earlier, we're in the market now with infrastructure with Asian real estate with impact. We are – we have raised and continue to raise additional SPACs. We'd expect to see more of that. We have some new products that we're working on that in all likelihood will be coming out in a meaningful way this year as well. On the credit side, a number of evergreen funds that are – have been fundraising and continue to fundraise large-cap originations that often syndicate to our LPs as well. So quite a bit of activity expected for 2021.

Thank you. Our next question comes from Robert Lee with KBW. Your line is open.

Thanks for taking my question. And Marc, quite a move from sabbatical to CEO. So hope congratulations are in order for you. I'm just curious, there's a lot of – going on in terms of investment in the business. Can you maybe update us on how you're thinking about how these initiatives we should be thinking about how they will impact kind of FRE margins going forward? You're already pretty high investment – best-in-class. So where do you think to go from here is I guess my first question.

Okay. Why don't I take that? So clearly in hindsight taking a sabbatical in the middle of pandemic is a very bad idea. First, I went nowhere and I did nothing. But in some sense it actually accomplished everything it was supposed to accomplish. The first half of 2020, I worked like an associate, new to a firm. We closed two of the largest insurance transactions in the insurance marketplace. And by the end of June, I needed a little bit of a break. And when I say it accomplished what it was supposed to accomplish with me sitting there every day the team that is way smarter than I am, that really makes things happen in the insurance business, never got to spread their wings. We now – with six months to have passed, we've settled into a routine that is completely sustainable, where I am involved in those things that add value where I can add value but where the day-to-day responsibility is in the hands of people, who as you will meet them in our various investor presentations, you will come to the same conclusion that I have which it gets better once you get past me. As it relates to FRE margins, I'll put it in the context of more of our five-year plan. 15 months ago, we sponsored an Investor Day. And I believe, when we rolled out the target, and we said $600 billion of AUM, I was watching the audience a number of faces dropped and thought that goal was unsustainable or unrealistic. 15 months later, we're halfway toward that target. The outcome of that target, since AUM is the fundamental driver of revenue is mid-double-digit growth for a very long period of time. As to growth and investment, in any particular year, it is not the revenue or the AUM that I so much focus on, or that you should be focused on. The decision in any given year as to whether we will grow double digit low or double-digit high will be primarily driven by the pace of investments in the front end, and we balance that very carefully. As you've heard me say already, I believe, we are in a growth business. We serve people, who are desperate for yield. Our institutional business is growing. Our insurance business is growing. Our retail business is growing. We need to make sure, we grow the front end, consistent with the AUM potential we have, rather than focus on growing AUM. Hopefully that answers your question.

Thank you. Our next question comes from Ken Worthington with JPMorgan. Your line is open.

Hi, good morning. Maybe more broadly in private equity, Apollo tends to be a value investor, and US market valuations are elevated based on a historic perspective. I know your announced pipeline looks quite good, but valuations are now quite elevated. And should we expect the pace of investment to start to slow here? And then, maybe on a tangent, does the SPAC market grow big enough to maybe further drive competition here, making it even harder to invest new investor dollars? Thanks.

Sure. So, look, as I've said in the past, market indexes aren't necessarily a good indicator of what's going on across the breadth of the market. The pipeline in the PD business is really stronger now than it's been at any time even through the crisis. And so, I would expect, if I had to estimate a bigger-than-average deployment year in private equity this year, just based on what we're seeing and what we have teed up even in the short to medium term. So, I actually think deployment across private equity, hybrid value, a number of our other opportunistic funds, notwithstanding the market backdrop is still incredibly strong. As far as your question around SPACs, look, we ultimately see SPACs, as an interesting asset class. It is not a flash in the pan. SPACs are here to stay for a lot of fundamental reasons. In some respects, is it competition? Sure, but we've always had competition. If anything, Apollo has now proven our ability to successfully issue SPACs. We've issued a number. We have several more in the pipeline and see it as a real opportunity to add to the asset category footprint that we have. And I think, you'll continue to see that be an increasing part of how we approach the market across the spectrum of risk and return.

Great. Thank you.

Thank you. Our next question comes from Bill Katz with Citigroup. Your line is open.

Okay. Thank you, very much, and Marc, congratulations as well. Maybe a question for Martin just to tie it together some big picture with maybe the operational side of things, could you dimension in the fourth quarter, how much of the G&A or other expenses were related to the inquiry? And then as you think about 2021, could you dimension a little bit about where you sort of see either comp ratio or the non-comp FRE drivers just given Marc's commentary about growing the front end?

Sure. So, I think Bill, the step-up in Q4 from Q3 on non-comp was effectively explained or was explained by the cost of the review. And so as we look forward, it's a slightly different answer for comp and non-comp. We are growing. We've added headcount and so it's natural to expect the cost of the firm continue to increase. On the non-comp side, we're looking at and we're engaged in new premises in many offices around the world including both New York and London. That comes with a cost. And so we manage non-comp very carefully and tightly. But as the headcount growth, the firm increases and the needs to support all our employee base increased then so do the cost. Comp comes back to -- I put that in the context of Marc's comments and that is we focus on FRE growth and we manage FRE growth relative to investments in the platform and building out the origination side and all the support that's needed for that with the revenue growth that comes with that. It's not a straight line, but we are very -- we have strong conviction in our mid-teens FRE growth rate as we look forward from here. And I would just echo Marc's comments that there's a range around that. It could be low double digit. It could be mid to high teens in any one year, but we manage that based on the opportunities to grow the platform in view of when we think the revenue will come.

Thank you. Our next question comes from Patrick Davitt with Autonomous Research. Your line is open.

Hi, good morning, everyone. I guess, the fundraising -- the 2021 fundraising from a different angle. I think you said around $49 million, $50 billion of the gross inflow last year was what you consider organic. So as you think about all the stuff you listed that's in the market or expected to be in the market this year, what do you think is a good range for gross fundraising relative to that number excluding your view of what Athene and the Athora deal volume could be?

So I'm going to start and then I'm going to turn it I guess to Martin. I think it's important to understand, how we come at this holistically. So there is Athene and Athora deal volume. But as you know we are in the re-tech market every day. This year organic growth at just Athene, north of $20 billion. We are among the largest providers of alternative asset services in the retail marketplace. We elect to do that though in the form of guaranteed income rather than in the form of funds. We can at a later date explore the efficiency of that. When we start a new fundraise, no matter, which fund it is, we start with a very important anchor relative to almost anyone else in our marketplace. And that anchor is our massive permanent capital vehicles. They are as you know mostly allocated to yield alternatives, which is high grade. In fact yield alternatives, which is how their business runs but roughly 5% of their portfolio is allocated to alternatives. Making sure that we deliver adequate alternative assets to our insurance platforms is a very important part of achieving the overall returns of the insurance company and it actually has a second benefit. It aligns us to a much greater degree with our investors in that we own in some instances 15% or 20% of a new alternatives fund relative to what a GP commitment might be. So with that intro, I will then turn over to Martin.

Great. So just I'll just put some -- a bit more color around that. We typically raise -- away from a year when we're reaching a big flagship fund in PE, we typically raise somewhere between $15 billion and $20 billion of third-party capital. And then in addition to that, we have organic growth at the insurance platforms plus we have insurance M&A. And then we have further deployment of assets in our insurance platforms as we reposition their balance sheets. So without any, sort of, unusually large M&A, without any flagship you're in the range of $40 billion to $50 billion a year give or take, and then with upside from there driven by the other two components.

Thank you. Our next question comes from Michael Cyprys with Morgan Stanley. Your line is open.

Hey, good morning. Thanks for taking the question. I was just hoping you guys could maybe provide a little bit of an update on some of the direct origination platforms that you've been building out ranging from mid-cap aircraft leasing some of the newer ones. How are those progressing? And maybe you could just talk about your plans for building those out further from here whether it's in terms of head count adds other appetite for other asset classes and such? Thanks.

Perfect. Jim, why don't you take that?

Great, thanks, Mike. Certainly, I would say, let's talk about the assessment of what we have in place versus growth. So as you highlighted mid-cap and PK both platforms that we entered 2020 strong objectives, and notwithstanding the challenges of March and April, strong years in both strong ROE at mid-cap and growth in the platform across all its activities. Same case with PK and merch where we put capital to work throughout the year and strong performance and a balance sheet that comes out in pristine shape. Both of those entities have a variety of great liquidity and additional equity that is – will be attaching or attracting over the several months. So, great growth out of those two. Marc also highlighted activities in the net lease space in the core plus and core space over in Europe and the U.S. two big growth areas for us. And I suspect, this year you'll see not only additional capital raise but deployment really first and foremost from our insurance balance sheets as Marc described, but also across the board from institutions as well which we're seeing a great demand from companies to think about how they think about their real estate considering what's going on in 2020. So a very, very strong pipeline there. I would say also, you know, we talked a lot about AOP our large-cap origination platform very healthy start to the first quarter of 2021. And finally, a lot of activities that you saw as a result last year, whether it was the ADNOC transaction, whether it was the Hertz securitization and dip whether it was the ABI transaction in the fourth quarter. So this whole large-cap and high-grade alpha which we are having a very, very strong end on so we see that – those are really the drivers and as Marc and Martin pointed out, we find ourselves in the enviable position that intellectual capital coming from the institutional sell-side from the big banks we are a partner of twice as they decide. And last year, across the firm, we brought in over 300 people. Many, many of those were high-quality individuals that we added to our origination platform. So, we feel like the opportunity has never been as strong as we sit here in the first quarter of 2021.

Thank you. Our next question comes from Jeremy Campbell with Barclays. Your line is open.

Hi. Thanks. Martin, just getting a couple of questions from investors this morning here on the performance fee side of the equation. I know, you had a little color about Fund VIII a couple of hundred million still left there. But just wondering, if you – and I know, it's a little market-dependent, but wondering if you have any line of sight around when Apollo might be able to work through those issues and we can start seeing funds – fees show back up in the P&L in a more robust fashion for private equity?

Yeah, Jeremy, we're virtually through the delay in realizations resulting from the impairment. In my comments, I referred to a $0.06 delay. So the next $0.06 of what would otherwise be no carry coming out is to the LPs. And then after that, we're in the clear. And so any monetizations from them will create carry. I think the further benefit is as Fund IX continues to invest, and as Scott mentioned, with a healthy pipeline in front of us, and now being in carry we have a good line of sight into multiple years of Fund VIII realizations, with Fund IX tacking on to the back end of that. So the clawback is not an issue. It's specific to old funds. It's not specific to Fund VIII at all and so that's not an issue in terms of realizations. So I think as we look forward, there's a ramp in front of us to get through into what we see as a more normalized monetization period and carry coming through the PE business.

Thank you. Our next question comes from Mike Carrier with Bank of America. Your line is open.

Good morning. Thanks for taking the question. I'm just seeing your comments on focusing on growth for the firm. Obviously, you guys have done a good job from an organic standpoint. So maybe away from insurance, just wanted to get your update on appetite for pursuing M&A to expand either in different strategies or geographies as we've seen some of your peers do?

Okay. Again, I'll start and then I'll hand it to Jim and Scott. And first, thank you for your comments and I look forward to -- at our next Investor Day exploring what I'm about to say in more detail. But to be provocative, I believe we're going to see more change in our industry over the next five years than we have in the past 10. If you step away and just think about what's happened, we've had a decade-plus of financial repression where investors who were relying on a certain set rate of guaranteed return or fixed income return have been unable to achieve that and they've been pushed further and further out on the risk spectrum to try and achieve any kind of normal return. To date that return has been met because we've been in a very interesting market. At the same time, what we've seen is, we've seen two other -- perhaps three other really big trends. Trend one is indexation. The more and more market gets indexed the more things fall out of an index and create interesting opportunity. Second is correlation. And the third is volatility as we're seeing in spades in this market. All three, I believe present interesting opportunities for us to invest around, for us to augment our franchise in ways perhaps unexpected. And with that I'll see if Scott wants to add anything.

Yes. Look, I think as we continue to grow into geographies, into products, into sectors, we're always looking at can we build it ourselves, can we bolt on small teams or do we have to take larger steps and make more sizable acquisitions. And so all of that's completely on the table. And as we just pursue these different options, I think you'll see more of a mix of all of that going forward.

Thank you. Our next question comes from Devin Ryan with JMP Securities. Your line is open.

Okay. Great. Good morning. I just want to talk a little bit more about the deployment backdrop and then maybe coming at it from some of the comments you just made, Marc. I mean, the perspective here is that the credit backdrop has recovered dramatically. Risk assets are at highs or close to it. And I know Apollo is always thinking about the upside opportunities, but also the downside risks. And so in a backdrop where it doesn't feel like there's being a lot of risk priced in broadly, how is that informing kind of the views on deployment? And I guess, what are some of the things you're looking at that are maybe different around deploying capital into this environment?

Sure. Why don't I hand that to Jim to start?

Sure. I mean, I really think the answer to that is looking back in our performance in 2020. If we had sat here a year ago and we described for you the litany of transactions from ADNOC to Expedia to Albertsons to ABI to both Hertz transactions, you would have said those were going to come out of the auspices of the banks. That was their regime. That's their opportunity. And so we have found ourselves in the enviable position of having expertise on sourcing, structuring, taking down and potentially syndicating those transactions. So the theme that we've talked about for several years, the evolution of intellectual capital from The Street to the buy side, the search for yield, the regulatory environment, our footprint, all the themes that Marc and Josh have been highlighting here, we just see those accelerating. And when we think about our pipeline for those transactions, which we think there's really just a handful of firms in the world that can do the execution, I just mentioned that's what excites us about our ability to grow. And also it's just -- it's the feedback loop to focusing more and more on that front end as Marc described. So I think the evolution of the business is constantly changing. Regardless of what happens in the regulatory front, we think that our robust model from sourcing and execution is really unmatched. And we expect that to continue not only in the US, but around the globe in Europe and in Asia. And in our view that's a real highlight of our growth opportunity.

Thank you. Our next question comes from Chris Harris with Wells Fargo. Your line is open.

Great. Thanks guys. So there's been a lot of focus obviously on existing LPs and their willingness to reallocate to Apollo. Now that the review is over, can you talk a bit about the prospects for an expansion of Apollo's LP base?

Sure. This is Jim. I think I can't emphasize enough. As Marc said, we are a massive platform of $425 billion. We have thousands of institutional investors and certainly we see what's going on in the evolution of savings with regard to the wirehouses, RIAs and several others. And I think you should expect to see us expand that types of fundraising channels in the appropriate yield channels over the coming year and years ahead. We have brought on some folks to do that. We have augmented the team and part of our budget in 2021 and 2022 will be to really accelerate that. I do think that when we think about our platform and the conversation that's going on about distribution channels, we think we're particularly well suited to do so. Again, if you look at the -- I know there's a question earlier about our pipeline of products. We currently have about 11 products in the market, four/five of those are really evergreen. The other six/seven are the episodic ones that Scott mentioned. And certainly, there's a scalability to a variety of things whether it's our Accord Series, whether it's our TRF Series, whatever we have going on in core and core plus. So we feel that we have a great portfolio to apply to that diversification. And again, I think we have a great list of institutional LPs, but certainly there's ways for us to expand that on a continued basis as well.

Thank you. Our next question comes from Gerry O'Hara with Jefferies. Your line is open.

Great. Thanks. Perhaps one the insurance outlook. I mean, clearly more entrants, more competition. So just kind of curious as to kind of any context or commentary you might be able to add as it relates to just more competition in that market. And also on a related basis, how we should think about the repositioning of last year's acquisitions. For example, did the market environment allow for an acceleration of that? Are you maybe more than 50% through it, or just some kind of context as it relates to those portfolios? Thank you.

Okay. It's Marc. I'll start with your second question and work backwards, which is to say ,I'm not going to steal Athene's thunder. They will be announcing results on the 17th. But in the commentary they've made to date, I know they are very pleased with how things are going. And some of the transactions that both Jim and Josh alluded to were anchored by our insurance company balance sheets both in the US and in Europe. Competition in any market is inevitable. People have seen now what we have built over the last 11 or 12 years and I assure you that we have paid substantial tuition. Buying something is not the same as integrating your business with an insurance company. Every morning at Apollo there are 150 people who wake up and do nothing other than insurance. The plumbing, the piping, the understanding of how assets get onboarded onto an insurance company balance sheet is different than making investments in insurance. It's different than managing money for insurance companies. It's a fundamentally different skill set. To delve in perhaps more than you wanted to what we have succeeded in doing in the insurance business is to create a virtuous circle. Insurance is a capital-intensive business. Every time you grow in insurance, you have to raise capital to support that growth from a regulatory point of view. What we have done is we have gotten to be so large and so profitable that we generate significant amounts of internal capital, so that we are able to continue to grow without necessarily raising new capital. If we want to grow really fast, yes, we augment the balance sheet by again integrating limited partners or integrating specific funds into our insurance company acquisitions. But it all starts with having a profitable…

Thank you. That's all the time we have for questions today. I'd like to turn the call back to Mr. Peter Mintzberg for closing remarks.

Thanks again for joining us today. We look forward to speaking with all of you again next quarter.

Ladies and gentlemen, this concludes today's conference call. Thank you for participating. You may now disconnect. Everyone have a great day.